<bill session="100" type="h" number="3547" updated="2014-03-22T09:52:53-04:00">
  <state datetime="1987-10-26">REFERRED</state>
  <status>
    <introduced datetime="1987-10-26"/>
  </status>
  <introduced datetime="1987-10-26"/>
  <titles>
    <title type="short" as="introduced">New Drug and Device Application Fee Amendments of 1987</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to impose fees under that Act for the review of applications for marketing approval for new human drugs, antibiotics, medical devices, and biological products, and for other purposes.</title>
  </titles>
  <sponsor id="407069"/>
  <cosponsors/>
  <actions>
    <action datetime="1987-10-26" state="REFERRED">
      <text>Referred to House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="1987-11-16">
      <text>Referred to Subcommittee on Health and the Environment.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Drugs"/>
    <term name="Administrative fees"/>
    <term name="Drug law and legislation"/>
    <term name="Drug safety and regulation"/>
    <term name="Drugs and narcotics"/>
    <term name="Health"/>
    <term name="Medical supplies"/>
  </subjects>
  <amendments/>
  <summary>10/26/1987--Introduced.
New Drug and Device Application Fee Amendments of 1987 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish fees to cover the costs of review for: (1) new drugs; (2) antibiotic drugs; (3) medical devices; and (4) biologic products licensing.</summary>
</bill>
